Acceleron Pharma revenue was $92.52 m in FY, 2020
Acceleron Pharma revenue breakdown by business segment: 18.9% from Cost-Sharing and 81.1% from License and Milestone
|FY, 2019||FY, 2018||FY, 2017|
|Cost-Sharing||13.99 m||13.99 m||12.94 m|
|License and Milestone||60 m||541 k|
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.